SV Health Managers LLP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
SV Health Managers LLP
CRD #301397
SEC #802-115123
CIK #0000301397
AUM
Employees
Phone00442074217070
Address71 Kingsway
London, United Kingdom
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Type Form D Funds Date Sold ($M) AUM ($M)
VC SV8 Biotech Fund LP [2026-03-24] 0.0 0.0
Filed 2025-06-12 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Dementia Discovery Fund 2 LP [2023-03-30] 201.7 252.3
Offered $350,000,000 · Filed 2025-01-08 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $148,330,651 · Duration More than one year · Revenue Decline to Disclose
VC SV Biotech Crossover Opportunities Fund LP [2022-03-31] 135.2 302.7
Offered $350,000,000 · Filed 2022-01-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $214,820,000 · Duration One year or less · Revenue Decline to Disclose
VC Dementia Discovery LP [2019-03-28] 26.0 252.4
Offered $302,381,000 · Filed 2017-10-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $276,413,669 · Duration More than one year · Revenue Not Applicable
VC SV7 Impact Medicine Fund LP [2019-03-28] 0.0 296.9
Offered $250,000,000 · Filed 2019-06-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $250,000,000 · Duration One year or less · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Michael Ross Executive Officer 88 5
Kate Bingham Executive Officer 8 3
Jonathan Behr Executive Officer 8 2
Houman Ashrafian Executive Officer 5 2
James Costine Executive Officer 4 2
Laurence Barker Executive Officer 4 2
Catherine Bingham Executive Officer 3 2
Hamish Cameron Executive Officer 2 2
SV Health Managers LLP Executive Officer, Promoter 5 1
SV Life Sciences Managers LLP Executive Officer 1 1
Christian Jung Executive Officer 1 1
SV7 IMF GP LLP Executive Officer 1 1
SV BCO I GP LLP Executive Officer 1 1
SV8 Bio GP LLP Executive Officer 1 1
Tetsuyuki Maruyama Executive Officer 1 1
Dementia Discovery General Partner LLP Executive Officer 1 1
Nicola Trbovic Executive Officer 1 1
DDF 2 GP LLP Executive Officer 1 1
Dementia Discovery GP LP Executive Officer 1 1
Terms | Privacy | Guide
tony@aum13f.com